As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration to sell their Prizma smartphone attachment direct to customers without the need for a prescription, rocketing the company’s share price. Prizma, a smartphone attachment which can monitor a user’s vital signs, can play a vital
Read More
As coronavirus fears continue to grip the global economy, send markets deep into the red and see a global shutdown of mass gatherings, technology will play a vital role in keeping the world interconnected, whilst in isolation. Panic buying has sent demand for healthcare products rocketing, leading to strong gains from medical product manufacturers but
Read More
Medtech innovator, G Medical Innovations (ASX: GMV), have experienced a significant boost in market confidence, following the news that the company has experienced 105% growth in their remote patient monitoring service in the US since January this year. The news saw GMV shares close at a striking 33.3% higher yesterday. The impressive year-on-year growth (CY2018-19)
Read More